Annual CFI
-$25.34 M
+$32.84 M+56.45%
December 31, 2023
Summary
- As of March 6, 2025, OPRX annual cash flow from investing activities is -$25.34 million, with the most recent change of +$32.84 million (+56.45%) on December 31, 2023.
- During the last 3 years, OPRX annual CFI has fallen by -$25.21 million (-20218.28%).
- OPRX annual CFI is now -238927.36% below its all-time high of -$10.60 thousand, reached on December 31, 2008.
Performance
OPRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$92.00 K
-$7000.00-8.24%
September 30, 2024
Summary
- As of March 6, 2025, OPRX quarterly cash flow from investing activities is -$92.00 thousand, with the most recent change of -$7000.00 (-8.24%) on September 30, 2024.
- Over the past year, OPRX quarterly CFI has increased by +$918.00 thousand (+90.89%).
- OPRX quarterly CFI is now -102.85% below its all-time high of $3.22 million, reached on June 30, 2023.
Performance
OPRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$26.33 M
+$918.00 K+3.37%
September 30, 2024
Summary
- As of March 6, 2025, OPRX TTM cash flow from investing activities is -$26.33 million, with the most recent change of +$918.00 thousand (+3.37%) on September 30, 2024.
- Over the past year, OPRX TTM CFI has dropped by -$8.51 million (-47.76%).
- OPRX TTM CFI is now -108013.52% below its all-time high of $24.40 thousand, reached on September 30, 2018.
Performance
OPRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OPRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.5% | +90.9% | -47.8% |
| 3 y3 years | -10000.0% | +7.1% | -5317.9% |
| 5 y5 years | -345.5% | +99.0% | -148.8% |
OPRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5113.4% | +56.5% | -102.8% | +99.8% | -5535.9% | +55.9% |
| 5 y | 5-year | <-9999.0% | +56.5% | -102.8% | +99.8% | <-9999.0% | +55.9% |
| alltime | all time | <-9999.0% | +56.5% | -102.8% | +99.8% | <-9999.0% | +55.9% |
OptimizeRx Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$92.00 K(+8.2%) | -$26.33 M(-3.4%) |
| Jun 2024 | - | -$85.00 K(-44.4%) | -$27.25 M(+13.8%) |
| Mar 2024 | - | -$153.00 K(-99.4%) | -$23.94 M(-5.5%) |
| Dec 2023 | -$25.34 M(-56.4%) | -$26.00 M(+2474.3%) | -$25.34 M(+42.2%) |
| Sep 2023 | - | -$1.01 M(-131.3%) | -$17.82 M(-67.2%) |
| Jun 2023 | - | $3.22 M(-308.0%) | -$54.32 M(-9.0%) |
| Mar 2023 | - | -$1.55 M(-91.6%) | -$59.66 M(+2.6%) |
| Dec 2022 | -$58.18 M(>+9900.0%) | -$18.48 M(-50.7%) | -$58.18 M(+46.2%) |
| Sep 2022 | - | -$37.51 M(+1668.5%) | -$39.79 M(+1522.7%) |
| Jun 2022 | - | -$2.12 M(+3123.1%) | -$2.45 M(+424.9%) |
| Mar 2022 | - | -$65.80 K(-33.5%) | -$467.20 K(-3.9%) |
| Dec 2021 | -$486.00 K(+289.7%) | -$99.00 K(-40.5%) | -$486.00 K(+4.2%) |
| Sep 2021 | - | -$166.50 K(+22.5%) | -$466.50 K(+45.6%) |
| Jun 2021 | - | -$135.90 K(+60.6%) | -$320.30 K(+65.5%) |
| Mar 2021 | - | -$84.60 K(+6.4%) | -$193.50 K(+55.0%) |
| Dec 2020 | -$124.70 K(-98.8%) | -$79.50 K(+291.6%) | -$124.80 K(-98.7%) |
| Sep 2020 | - | -$20.30 K(+123.1%) | -$9.57 M(+0.1%) |
| Jun 2020 | - | -$9100.00(-42.8%) | -$9.56 M(-9.7%) |
| Mar 2020 | - | -$15.90 K(-99.8%) | -$10.58 M(+0.0%) |
| Dec 2019 | -$10.58 M(+86.1%) | -$9.52 M(>+9900.0%) | -$10.58 M(+58.7%) |
| Sep 2019 | - | -$13.70 K(-98.7%) | -$6.67 M(+0.0%) |
| Jun 2019 | - | -$1.03 M(+7392.0%) | -$6.67 M(+17.7%) |
| Mar 2019 | - | -$13.80 K(-99.8%) | -$5.66 M(-0.4%) |
| Dec 2018 | -$5.69 M(>+9900.0%) | -$5.61 M(>+9900.0%) | -$5.69 M(<-9900.0%) |
| Sep 2018 | - | -$10.50 K(-67.9%) | $24.40 K(-535.7%) |
| Jun 2018 | - | -$32.70 K(-10.7%) | -$5600.00(-91.1%) |
| Mar 2018 | - | -$36.60 K(-135.1%) | -$62.70 K(+48.6%) |
| Dec 2017 | -$42.20 K(-87.9%) | $104.20 K(-357.3%) | -$42.20 K(-84.4%) |
| Sep 2017 | - | -$40.50 K(-54.9%) | -$270.90 K(-22.5%) |
| Jun 2017 | - | -$89.80 K(+457.8%) | -$349.40 K(-0.1%) |
| Mar 2017 | - | -$16.10 K(-87.1%) | -$349.80 K(+0.1%) |
| Dec 2016 | -$349.50 K | -$124.50 K(+4.6%) | -$349.50 K(+59.7%) |
| Sep 2016 | - | -$119.00 K(+31.9%) | -$218.90 K(+37.1%) |
| Jun 2016 | - | -$90.20 K(+470.9%) | -$159.70 K(+70.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$15.80 K(-359.0%) | -$93.90 K(-6.9%) |
| Dec 2015 | -$101.00 K(-75.4%) | $6100.00(-110.2%) | -$100.90 K(-47.7%) |
| Sep 2015 | - | -$59.80 K(+145.1%) | -$192.90 K(-20.7%) |
| Jun 2015 | - | -$24.40 K(+7.0%) | -$243.30 K(-24.8%) |
| Mar 2015 | - | -$22.80 K(-73.5%) | -$323.50 K(-21.1%) |
| Dec 2014 | -$410.00 K(+37.3%) | -$85.90 K(-22.1%) | -$410.00 K(-21.5%) |
| Sep 2014 | - | -$110.20 K(+5.4%) | -$522.20 K(+10.1%) |
| Jun 2014 | - | -$104.60 K(-4.3%) | -$474.30 K(+25.6%) |
| Mar 2014 | - | -$109.30 K(-44.8%) | -$377.60 K(+26.4%) |
| Dec 2013 | -$298.60 K(+486.6%) | -$198.10 K(+218.0%) | -$298.70 K(+196.9%) |
| Sep 2013 | - | -$62.30 K(+688.6%) | -$100.60 K(+203.0%) |
| Jun 2013 | - | -$7900.00(-74.0%) | -$33.20 K(-30.3%) |
| Mar 2013 | - | -$30.40 K(<-9900.0%) | -$47.60 K(-6.5%) |
| Dec 2012 | -$50.90 K(-78.8%) | $0.00(-100.0%) | -$50.90 K(-62.7%) |
| Sep 2012 | - | $5100.00(-122.9%) | -$136.40 K(-36.0%) |
| Jun 2012 | - | -$22.30 K(-33.8%) | -$213.10 K(-9.7%) |
| Mar 2012 | - | -$33.70 K(-60.6%) | -$236.00 K(-1.6%) |
| Dec 2011 | -$239.90 K(+6.3%) | -$85.50 K(+19.4%) | -$239.90 K(+14.6%) |
| Sep 2011 | - | -$71.60 K(+58.4%) | -$209.30 K(+17.1%) |
| Jun 2011 | - | -$45.20 K(+20.2%) | -$178.70 K(-18.2%) |
| Mar 2011 | - | -$37.60 K(-31.5%) | -$218.50 K(-3.1%) |
| Dec 2010 | -$225.60 K(+109.5%) | -$54.90 K(+33.9%) | -$225.60 K(-19.0%) |
| Sep 2010 | - | -$41.00 K(-51.8%) | -$278.40 K(+17.3%) |
| Jun 2010 | - | -$85.00 K(+90.2%) | -$237.40 K(+55.8%) |
| Mar 2010 | - | -$44.70 K(-58.5%) | -$152.40 K(+41.5%) |
| Dec 2009 | -$107.70 K(+916.0%) | -$107.70 K(<-9900.0%) | -$107.70 K(-682.2%) |
| Sep 2009 | - | $0.00(0.0%) | $18.50 K(0.0%) |
| Jun 2009 | - | $0.00(0.0%) | $18.50 K(-660.6%) |
| Mar 2009 | - | $0.00(-100.0%) | -$3300.00(-69.2%) |
| Dec 2008 | -$10.60 K(-91.6%) | $18.50 K(>+9900.0%) | -$10.70 K(-63.4%) |
| Sep 2008 | - | $0.00(-100.0%) | -$29.20 K(0.0%) |
| Jun 2008 | - | -$21.80 K(+194.6%) | -$29.20 K(+294.6%) |
| Mar 2008 | - | -$7400.00 | -$7400.00 |
| Dec 2007 | -$125.60 K | - | - |
FAQ
- What is OptimizeRx annual cash flow from investing activities?
- What is the all time high annual CFI for OptimizeRx?
- What is OptimizeRx annual CFI year-on-year change?
- What is OptimizeRx quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for OptimizeRx?
- What is OptimizeRx quarterly CFI year-on-year change?
- What is OptimizeRx TTM cash flow from investing activities?
- What is the all time high TTM CFI for OptimizeRx?
- What is OptimizeRx TTM CFI year-on-year change?
What is OptimizeRx annual cash flow from investing activities?
The current annual CFI of OPRX is -$25.34 M
What is the all time high annual CFI for OptimizeRx?
OptimizeRx all-time high annual cash flow from investing activities is -$10.60 K
What is OptimizeRx annual CFI year-on-year change?
Over the past year, OPRX annual cash flow from investing activities has changed by +$32.84 M (+56.45%)
What is OptimizeRx quarterly cash flow from investing activities?
The current quarterly CFI of OPRX is -$92.00 K
What is the all time high quarterly CFI for OptimizeRx?
OptimizeRx all-time high quarterly cash flow from investing activities is $3.22 M
What is OptimizeRx quarterly CFI year-on-year change?
Over the past year, OPRX quarterly cash flow from investing activities has changed by +$918.00 K (+90.89%)
What is OptimizeRx TTM cash flow from investing activities?
The current TTM CFI of OPRX is -$26.33 M
What is the all time high TTM CFI for OptimizeRx?
OptimizeRx all-time high TTM cash flow from investing activities is $24.40 K
What is OptimizeRx TTM CFI year-on-year change?
Over the past year, OPRX TTM cash flow from investing activities has changed by -$8.51 M (-47.76%)